NICE - NICE Ltd.
NASDAQ
->
Technology
->
Software—Application
Ra'anana,
Israel
Type: Equity
NICE price evolution
NICE
| (in millions $) | 15 Aug 2024 | 30 Jul 2024 | 27 Mar 2024 | 16 Nov 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1503.6 | $1407.84 | $1651.59 | |
| Short term investments | $216.91 | $228.31 | $299.07 | |
| Net receivables | $580.1 | $580.1 | $676.73 | $537.95 |
| Inventory | ||||
| Total current assets | $2300.61 | $2300.61 | $2312.88 | $2488.61 |
| Long term investments | $2751.21 | $2804.75 | $2407.38 | |
| Property, plant & equipment | $181.69 | $280.65 | $174.41 | $170.62 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $5051.82 | $5051.82 | $5117.63 | $4895.99 |
| Current liabilities | ||||
| Accounts payable | $73.13 | $73.13 | $66.04 | $57 |
| Deferred revenue | ||||
| Short long term debt | $209.23 | $181.13 | ||
| Total current liabilities | $938.37 | $938.37 | $1120.32 | $1016.58 |
| Long term debt | $457.93 | $457.93 | $457.08 | $456.65 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1596.65 | $1596.65 | $1776.5 | $1677.11 |
| Shareholders' equity | ||||
| Retained earnings | $2262.9 | |||
| Other shareholder equity | $3567.73 | $3455.17 | $3447.09 | $3341.13 |
| Total shareholder equity | $3455.17 | $3341.13 | $3218.88 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 5 Apr 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1407.84 | $1571.54 | $1424.75 | $442.27 |
| Short term investments | $228.31 | $237.42 | $379.05 | $1021.61 |
| Net receivables | $585.15 | $515.73 | $494.08 | $389.94 |
| Inventory | ||||
| Total current assets | $2312.88 | $2415.96 | $2297.88 | $1942.32 |
| Long term investments | $2804.75 | $2437.29 | $2412.53 | |
| Property, plant & equipment | $278.98 | $262.18 | $145.65 | $164.78 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2290.6 | |||
| Total investments | ||||
| Total assets | $5117.63 | $4856.18 | $4710.41 | $4232.92 |
| Current liabilities | ||||
| Accounts payable | $66.04 | $56.02 | $36.12 | $33.13 |
| Deferred revenue | $311.85 | |||
| Short long term debt | $209.23 | $209.29 | $395.95 | $259.88 |
| Total current liabilities | $1120.32 | $1144.29 | $1269.59 | $1044.45 |
| Long term debt | $457.08 | $455.38 | $429.27 | $421.34 |
| Total noncurrent liabilities | $599.98 | |||
| Total debt | $795.89 | |||
| Total liabilities | $1776.5 | $1814.1 | $1885.33 | $1644.43 |
| Shareholders' equity | ||||
| Retained earnings | $4386.39 | $3877.43 | $1653.96 | $1454.39 |
| Other shareholder equity | $3341.13 | $3042.09 | -$39.74 | -$16.66 |
| Total shareholder equity | $3341.13 | $3042.09 | $2825.09 | $2563.91 |
| (in millions $) | 15 Aug 2024 | 30 Jul 2024 | 27 Mar 2024 | 16 Nov 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $664.4 | $623.19 | $601.34 | |
| Cost of revenue | $224.78 | $200.88 | $190.99 | |
| Gross Profit | $439.62 | $422.31 | $410.36 | |
| Operating activities | ||||
| Research & development | $86.52 | $81.12 | $84.85 | |
| Selling, general & administrative | $224.27 | $218.53 | $211.88 | |
| Total operating expenses | $535.58 | $500.53 | $487.72 | |
| Operating income | $128.82 | $122.67 | $113.63 | |
| Income from continuing operations | ||||
| EBIT | $128.82 | $122.67 | $113.63 | |
| Income tax expense | $28.68 | $38.38 | $28.31 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $115.78 | $81.65 | $92.35 | |
| Income (for common shares) | $115.78 | $81.65 | $92.35 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2377.51 | $2181.29 | $1648.02 | |
| Cost of revenue | $561.95 | |||
| Gross Profit | $1609.34 | $1497.61 | $1086.06 | |
| Operating activities | ||||
| Research & development | $218.18 | |||
| Selling, general & administrative | $624.12 | |||
| Total operating expenses | $1160.12 | $1162.38 | $1404.25 | |
| Operating income | $243.77 | |||
| Income from continuing operations | ||||
| EBIT | $243.77 | |||
| Income tax expense | $119.4 | $79.39 | $40.84 | |
| Interest expense | $22.47 | $10.16 | -$21.07 | |
| Net income | ||||
| Net income | $338.3 | $265.94 | $196.67 | |
| Income (for common shares) | $196.67 | |||
| (in millions $) | 15 Aug 2024 | 30 Jul 2024 | 27 Mar 2024 | 16 Nov 2023 |
|---|---|---|---|---|
| Net income | $115.78 | $81.65 | $92.35 | |
| Operating activities | ||||
| Depreciation | $51.52 | $41.21 | $42.27 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $169.67 | $180.5 | $120.61 | |
| Investing activities | ||||
| Capital expenditures | -$21.69 | -$19.95 | -$17.99 | |
| Investments | ||||
| Total cash flows from investing | -$75.71 | $82.86 | -$317.34 | $88.81 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$1262.58 | -$969.84 | -$1312.88 | |
| Total cash flows from financing | -$145.57 | -$275.41 | -$69.58 | -$89.49 |
| Effect of exchange rate | -$3.25 | |||
| Change in cash and equivalents | $1503.6 | $228.36 | $1407.84 | $1651.59 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 5 Apr 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $199.57 | $196.67 | ||
| Operating activities | ||||
| Depreciation | $184.09 | $182.03 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $461.82 | $480.31 | ||
| Investing activities | ||||
| Capital expenditures | -$24.77 | -$24.19 | ||
| Investments | -$254.52 | |||
| Total cash flows from investing | -$293.58 | -$152.35 | -$261.5 | -$465.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$978.59 | $236.24 | ||
| Total cash flows from financing | -$290.27 | -$164.5 | -$261.82 | $196.84 |
| Effect of exchange rate | $2.64 | -$8.43 | $1.87 | |
| Change in cash and equivalents | -$19.78 | $154.44 | -$39.13 | $213.94 |
News
Fundamentals
| Market cap | $8.61B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 60.96M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 14.33% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | -76.53 |
| Book/Share | -1.85 |
| Cash/Share | 24.67 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.53 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.45 |
| Quick ratio | 2.45 |